Relationship between bladder cancer and total fluid intake: a meta-analysis of epidemiological evidence by Yunjin Bai et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Bai et al. World Journal of Surgical Oncology 2014, 12:223
http://www.wjso.com/content/12/1/223RESEARCH Open AccessRelationship between bladder cancer and total
fluid intake: a meta-analysis of epidemiological
evidence
Yunjin Bai†, Haichao Yuan†, Jinhong Li, Yin Tang, Chunxiao Pu and Ping Han*Abstract
Objectives: Epidemiological findings regarding the association between total fluid intake and bladder cancer risk
have yielded varying results. Our objective is to examine the possible associations between total fluid intake and
bladder cancer risk.
Methods: Databases searched include the EMBASE and PUBMED, from inception to February 2014, with no limits
on study language. We also reviewed the reference lists of identified studies. Stratified analyses were performed. A
random-effect model was used to summarize the estimates of odds ratio (OR) with 95% confidence intervals (CI).
Results: Overall,17 case-control and four cohort studies were included. The overall OR of bladder cancer for the
highest versus the lowest fluid intake was 1.06 (95% CI: 0.88-1.27). In the subgroup analyses, the overall ORs for
coffee, green, and black tea intake were 1.17 (95% CI: 1.03-1.33), 0.76 (95% CI: 0.66-0.95), and 0.80 (95% CI: 0.65-0.97),
respectively. A significantly decreased risk was observed in Asian people (OR 0.27; 95% CI: 0.10-0.72). Among
smokers, a suggestive inverse association was observed between total fluid intake and overall bladder cancer risk
(OR 0.80; 95% CI: 0.62-1.02).
Conclusions: Although this meta-analysis suggested that greater consumption of fluid may have a protective effect
on bladder cancer in Asian people, there was no convincing evidence on this association because of the limitations
of the individual trials.
Keywords: Bladder neoplasms, Fluid consumption, Etiology, Meta-analysisReview
Introduction
Bladder cancer is one of the most common malignant
tumors in the United States, with an estimated 74,690 new
cases and 15,580 deaths in 2014 [1]. Approximately 30% of
cases present as an invasive muscle bladder cancer, which
has a poorer prognosis [2]. To date, feasible measures for
the prevention of bladder cancer remain limited. A better
understanding of the etiology of bladder cancer may lead to
marked reductions in both the incidence and mortality.
The cause of bladder cancer is not well-known, but
multiple risk factors have been identified, including to-
bacco use, occupational exposure to chemicals found in* Correspondence: hanpingwch@163.com
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unless otherwise stated.the chemical and rubber industries, schistosomal chronic
infection, and high concentrations of arsenic in the
drinking water [3]. In recent years certain medications
have been investigated in several studies. Results sug-
gested that pioglitazone treatment was associated with
an increased risk of bladder cancer in patients with type
2 diabetes, and that exposure to herbs containing aristo-
lochic acids has also been associated with bladder cancer
[4,5]. As for other cancers, dietary aspects have been
responsible for the occurrence and development of blad-
der cancer. Some research has shown that processed
meat consumption may increase the risk [6], and the
intake of fruits and vegetables may decrease the risk [7].
Fluid intake is also commonly evaluated because of its
impact on voiding, but the association with bladder cancer
remains controversial. To date, studies on the relationship
between fluid intake and bladder cancer risk have yieldedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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consumption may reduce exposure of bladder epithelium
to carcinogens by diluting urine and increasing the
urination frequency. On the other hand, the type of fluid
is related to the risk if it is contaminated with carcinogens,
such as chlorination byproducts or arsenic [8]. In 2006, a
pooled analysis suggested that high fluid consumption
may increase the risk of bladder cancer [9], whereas recent
findings from case-control study and a randomized con-
trolled trial did not support such an association [10,11].
Therefore, a synthesis of the current evidence is needed.
To this end, we conducted a meta-analysis of all
published case-control and cohort studies to assess the
relationship between total fluid consumption and bladder
cancer risk.Methods
According to the Meta-Analysis of Observational Studies
in Epidemiology guidelines for study reporting [12], a
prospective protocol of objectives, literature search
strategies, eligibility criteria, and methods of statistical
analysis was prepared.Literature search
In accordance with a pre-specified study protocol, a
comprehensive electronic database search of PubMed and
EMBASE was performed to identify articles published up
to February 2014. Search terms included ‘fluid or water or
diet or dietary’ and ‘bladder cancer or urothelial cancer or
transitional or bladder neoplasm or bladder carcinoma’.
No language limitations were imposed. We evaluated
potentially relevant publications by examining their titles
and abstracts and all of the studies matching the eligibility
criteria were included. Moreover, the bibliographies of all
studies included were manually searched to identify
additional studies.Inclusion criteria
For a study to be included, in this meta-analysis, it was
necessary for it to meet all of the following criteria: (1)
case-control or cohort study assessing the relationship
between total fluid intake and bladder cancer risk, (2)
exact data in both case and control groups (participants
for cohort studies) should be determined and (3) results
including adjusted effect estimates with their 95% CIs or
sufficient information allowing us to calculate them. Studies
with overlapping or insufficient data were excluded. Letters,
abstracts, editorials, animal trails, and literature reviews
were excluded from this meta-analysis. Throughout the
process, any questions or discrepancies were resolved by
the consensus of all authors.Data extraction
According to the pre-specified protocol, all data were
extracted independently by two authors. We extracted the
following data from each eligible study by using a standard-
ized data collection form: the first author’s name, the year of
publication, the country where the study was conducted,
sex, sample size, the adjustment for potential confounders,
and effect estimates comparing the highest level of total
fluid intake with the lowest. Given that bladder cancer is a
rare disease, the relative ratio (RR) was assumed to be the
same as the odds ratio (OR). Consequently, we report all
results as ORs. The overall fluid definition as ‘fluid intake’ or
‘total fluid’ included fluid defined in the publications. To
avoid residual confounding by smoking and to assess effects
by smoking strata, we also extracted ORs for non-smokers.
Methodological quality assessment
The Newcastle-Ottawa Scale (NOS) [13] was used to as-
sess the methodological quality of cohort and case-control
studies on three broad perspectives: selection, comparabil-
ity, and exposure or outcome. Two authors read each study
and scored them independently. Disagreement between
the two authors was settled by discussion with the third
author and resolved by consensus.
Statistical analysis
The ORs were abstracted from each included study and
then transformed to their natural logs. The log of the ORs
was weighted by the inverse of their variances to obtain a
pooled OR with 95% CI. Statistical heterogeneity among
studies was measured using the Q-test [14] and calculating
the I2 score [15]. For the Q-test, heterogeneity was consid-
ered present for P<0.10. The I2 exceeding 50% is considered
to indicate the presence of heterogeneity. In cases of a lack
of heterogeneity, the Mantel-Haenszel fixed-effect model
was used to provide summary estimations of the total fluid
intake associated with bladder cancer risk, otherwise, the
DerSimonian and Laird random-effect model was used for
the meta-analysis [14,16].
Publication bias was assessed through the visual
inspection of funnel plots and with tests of Begg rank
correlation [17] and Egger regression asymmetry [18].
P<0.05 was considered to be representative of a signifi-
cant statistical publication bias. To explore the potential
heterogeneity among studies, subgroup analyses were
conducted according to gender (male and female), study
design (cohort and case-control studies), geographical
region (Europe and Asia), smoking status (non-smoker
and smoker), publication year (before2000 and after
2000), type of beverage (water, coffee, tea and alcoholic
beverages), and number of beverages. Statistical signifi-
cance was set at P<0.05. STATA version 12.0software
was used for the statistical analyses (StataCorp, College
Station, Texas, United States).
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Search result and characteristics of included studies
Using the predefined search strategies, we ultimately
included 21 articles [9,10,19-37] that investigated the
association of total fluid intake with bladder cancer risk,
including 17 case-control [9,10,19-33] and four cohort
studies [34-37]. The flow diagram (Figure 1) showed the
detailed literature search steps. Among the 17 case-
control studies, 9 studies [10,21,23,25,27-29,31,33] re-
ported 2 separate outcomes (male and female). Of the
four cohort studies, one study [36] reported two separate
outcomes (male and female). Six studies [10,21,29,34-36]
were eligible for pooling estimates of total fluid intake
among non-smokers (three cohort studies). Baseline char-
acteristics of the eligible studies are presented in Tables 1
and 2. Of these studies, 17 [10,19,23-36] were conducted
in Europe and North America (9 in the United States, 8 in
other countries) and 4 [10,20-22] in Asia.
Total fluid intake and risk of bladder cancer
Risk estimates for highest versus lowest level of total fluid
consumption are shown in Figure 2. The summary OR
with 95% CI (1.06 95% CI: 0.88-1.27) of all studies, using a
random effects model, showed a statistically significant
association between the highest fluid intake and the
risk of bladder cancer. There was statistically significant
heterogeneity among studies (P<0.001, I2 = 82.8%).Figure 1 Flow diagram of studies identified, included,
and excluded.Subgroup meta-analysis
To explore the source of the heterogeneity, we conducted
subgroup meta-analysis by various study characteristics
(Table 3). In an analysis stratified by study design, the
summary OR from cohort studies (OR 0.98; 95% CI 0.85-
1.13) showed that there was no association for the highest
fluid intake with the risk of bladder cancer, but in case-
control studies (OR 1.07; 95% CI 0.86-1.33) showed a
significant association. When stratified by geographical re-
gion, studies conducted in Europe and North America did
not change the overall OR of all studies (OR 1.20; 95% CI
1.02-1.42), but there is a statistically significant protective
effect of the highest fluid intake on bladder cancer in Asia
(OR 0.27; 95% CI 0.10-0.72). When we separated the
population-based case-control studies from the hospital-
based case-control studies, we found that hospital-based
studies markedly changed the summary OR of all studies
(OR 0.71, 95% CI 0.44-1.15), in that greater fluid intake
was related to decreased bladder cancer risk. Moreover, to
avoid inadequate adjustment for tobacco smoking in the
included studies, we evaluated the influence of the smok-
ing status. The results showed that the smoking status did
not influence the summary ORs substantially (Table 3).
Interestingly, we found green and black tea have an inverse
association for the highest tea intake with the risk of blad-
der cancer (OR 0.76, 95% CI 0.66-0.95; OR 0.80, 95% CI
0.65-0.97, respectively), but no statistical significance. The
majority of them were not identified as a possible source of
heterogeneity among all studies included (Table 3).
Qualitative assessment and publication bias
The results of qualitative assessment of the studies
included in our meta-analysis were shown in Tables 1
and 2. All of them were given a score of 6 to 8 stars. There
was no funnel plot asymmetry for the association between
total fluid intake and risk of bladder cancer, P values for
Begg’s adjusted rank correlation test was 0.244, and the
Egger’s regression asymmetry test was 0.059, which
suggested that there was no evidence of publication
bias in this meta-analysis (Figure 3).
Discussion
Dietary intervention is an attractive, valuable, and noninva-
sive means to prevent cancer. Fluid intake may impact the
development of bladder cancer along with multiple path-
ways, ranging from carcinogenesis to cellular apoptosis.
However, contradictory conclusions were summarized by
different research centers. Therefore, we conducted this
meta-analysis to assess the potential relationship between
total fluid intake and bladder cancer risk, and the summary
OR indicated that there was no significant association
between them.
To further illustrate the relationship, stratified analyses
were performed, and the finding of subgroup analysis of
Table 1 Study characteristics of published case–control studies of total fluid intake and bladder cancer risk
References, year
of publication






Effect estimates Adjustment factors Observations
Wang et al. 2013 [19] USA F/M 1,007/1,299 ≥2789 vs. <1696 ml/day 8 1.41 (1.10-1.81) Age, sex, ethnicity, energy
intake, and smoking.
Coffee, tea, water, alcoholic
beverage, soft drink
Ahmad et al. 2012 [20] Pakistan F/M 55/99 ≥10 vs. <10 glasses/day 6 0.116 (0.04-0.33) NA Coffee, tea, alcohol







Hemelt et al. 2010 [21] China F/M 432/392 The highest vs.
lowest quintile
7 0.65 (0.43-0.98) Age, sex, smoking status,
smoking frequency,
smoking duration
Black tea, green tea, fruit juice,
milk, soft drinks and water,




Pakistan F/M 50/100 ≥10 vs. <10 glasses/day 6 0.025 (0.005-0.115) NA Coffee, tea, alcohol
Jiang et al. 2008 [23] USA F/M 1,586/1,586 The highest vs.
lowest quartile
6 0.98 (0.77-1.26) Education, NSAIDs, intake of
carotenoids, hairdresser/
barber, cigarette smoking
status, duration and intensity
of smoking
Water, coffee, tea, alcohol, milk,
juice, hot chocolate, and soda
F:1.19 (0.67-2.09)
M:0.93 (0.71-1.24)
Michaud et al. 2007 [24] Spain F/M 397/664 The highest vs.
lowest quintile
7 0.62 (0.40-0.95) Age, sex, region, cigarette smoking,
high-risk occupation, nighttime
urination frequency, THM levels,
non-tap fluid for water intake
Coffee, beer, wine,
liquor, champagne, soda,
juices, tea, milk, and water




water, non-tap waterM:1.33 (1.12-1.58)
Geoffroy-Perez and
Cordier 2001 [25]
France F/M 765/765 F: >12800 vs. ≤7300
ml/week M: >16800
vs. ≤8300 ml/week
6 F: 0.96 (0.42-2.22) Age, center, and place of
residence, and smoking
Tap water, coffee, tea,
bottled alcohol
F: 106/106
M: 602/615 M: 1.07 (0.72-1.59)
Bianchi et al. 2000 [26] USA F/M 1,452/2,434 ≥2.6 vs. <2.6 l/day 7 1.32 (1.16-1.51) Age, education, smoking, pack-years
of smoking, family history of bladder
cancer, high risk occupation, total
beverage consumption, years of
chlorinated surface water,
vegetable, coffee consumption
Water, coffee, tea, fruit
juices/drinks, soups,
milk, soft drinks, and
alcoholic beverages
Pohlabeln et al. 1999 [27] Germany F/M F:61/61 F:>2 l/day vs. <1 l/day
M:>3 l/day vs. <1 l/day
6 F:0.34 (0.11-0.99) Smoking Coffee, tea, water, wine, bottles
of beer, and other beverages
M:239/239 M:1.52 (0.64-3.59)
Bruemmer et al. 1997 [28] USA F/M 262/405 >12 vs. ≤7 cups/week 6 F: 4.7 (1.4-15.8) Age, county, and smoking Water, coffee, decaffeinated coffee,
tea, diet soft drinks, regular soft


















Table 1 Study characteristics of published case–control studies of total fluid intake and bladder cancer risk (Continued)
Wilkens et al. 1996 [29] USA F/M F: 66/132 The highest vs.
lowest quartile
7 F: 0.3 (0.1-0.8) Age, smoking status, pack-years,
high-risk occupation, dark
green vegetables in men,
total vitamin C consumption
in women
Coffee, black and green tea, soda,
beer, spirits, wine, fruit juice,
cocoa, water, and milkM: 195/390 M: 1.4 (0.8-2.6)
Vena et al. 1993[30] USA F/M 351/855 The highest vs.
lowest quartile





beverages, soda, milk, coffee,
tea, all juices, and glasses
of tap water
Kunzeet al. 1992 [31] Germany F/M F:75/71 F:1.1-2.0 vs.2.1-3.0 l/day 6 F:0.9 (0.3-2.5) Smoking Coffee, tea, beer, high-proof
spirits, wine, all nonalcoholic,
alcoholic beveragesM:416/360 M:1.1-2.0vs. >3.1 l/day M:4.9 (2.0-12.3)
Slattery et al. 1988 [32] USA F/M 419/889 >653 vs. ≤289 oz./week 6 1.36 (0.89-2.07) Age, sex, diabetes, bladder
infections, and cigarette
smoking
Coffee, tea, soft drinks, water, milk,
cocoa, chocolate milk, fruit and
vegetable juice, other non-alcoholic
beverages, alcoholic beverages
Jensen et al. 1986 [33] Denmark F/M 371/771 F: 3-3.99 vs. 0-0.99 l/day 7 F:1.8 (0.4-1.4) Smoking Coffee, tea, beer, and soft drinks
as well as other beverages
M:≥4.00vs. 0-0.99 l/day M:3.3 (1.4-7.4)


















Table 2 Study characteristics of published cohort studies of total fluid intake and bladder cancer risk
References, year
of publication









Zhou et al. 2014 [34] USA F 160,041/427 The highest vs.
lowest quartile
7 0.83 (0.61-1.12) Age in years, pack-years of smoking (5 categories),
current smoking status (yes vs no), consumption
of bacon (3 categories), energy intake (in quartiles),
and intake of fruit and vegetables (in quartiles)
Water and specific beverages
Zhou et al. 2012 [35] USA F/M 924,221/823 >2,531 vs. <
1,290 ml/day
7 1.02 (0.79-1.32) Geographic region, age, pack-years of smoking,
current smoking status, energy intake, intake
of meat, and intake of fruits and vegetables
Water, milk, soda, coffee, fruit juice
Ros et al. 2011 [36] European F/M 233,236/513 F: >2046 vs.
<1,438 ml/day
8 1.12 (0.86-1.45) Age at entry, sex and centre and adjusted
for smoking status, duration of smoking,
lifetime intensity of smoking, energy
intake from fat and nonfat sources
Alcoholic beverages, milk and other
dairy beverages, coffee, tea, herbal




<1,735 ml/day M: 1.09 (0.79-1.5)
Zeegers et al. 2001 [37] Netherlands F/M 120,852/569 The highest vs.
lowest quintile
7 0.91 (0.65-1.29) Age, sex, number of cigarettes/day,
years of cigarette smoking, coffee
consumption, and tea consumption
Water, milk, juice, soda and lemonade,
alcoholic beverages, coffee, and tea


















Figure 2 Forest plot of the association between total fluid intake and bladder cancer risk.
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fluid intake was related to decreased bladder cancer risk.
However, meta-analysis of observational studies presented
particular challenges because of inherent biases, residual
confounding, and chance that might diminish the validity
of a systematic review. The potential bias of case-control
studies, such as selection and recall bias, might contribute
to the discrepancy between case-control and cohort studies.
Therefore, considering this condition, caution is needed in
interpreting the findings from the meta-analysis.
Several potential mechanisms have been proposed to
explain the associations of fluid intake and bladder
cancer risk. A higher level of fluid consumption could
reduce the contact time between urinary carcinogens
and the bladder urothelium through increasing urination
frequency, which could reduce the risk of bladder cancer
[23,38,39]. We should note that the amount of total fluid
ingested and urination frequency may not present a
positive correlation among older men because of benign
prostatic hyperplasia, which can cause frequent micturition
[35]. Furthermore, urination frequency is related to differ-
ent weather conditions, which may partly explain some of
the geographic differences [35].
However, given that fluids may carry carcinogens to
the bladder, another hypothesis was proposed to explain
the increased risk. An increase in total fluid consump-
tion may extend the bladder wall and introduce the
carcinogens to the deeper layer of the bladder urothe-
lium, which inevitably results in the formation of DNAadducts that may induce the critical mutations needed
for tumorigenesis [40]. Thus, increased fluid consump-
tion will increase the risk of bladder cancer. A meta-
analysis found that high concentrations of arsenic in the
drinking water (>50 μg/L) was associated with an in-
creased risk of bladder cancer incidence and mortality
[3]. However, the mechanisms of the effect of fluid
intake on bladder cancer require further research.
The role of total fluid intake is further complicated
because of the possibility that different types of fluid may
have different effects on bladder cancer. We evaluated
specific fluid items, including water, tea, coffee, and
alcoholic beverages. Inconsistent with the previous
findings that water intake contributed to a lower risk
[10,24], we found that a greater water intake may increase
the risk but the relationship is weak. This discrepancy
may be due to differences in exposures to chlorine
and chlorination by-products [41,42]. Unfortunately, we
did not collect information on the source of drinking
water because of the limitations of the included studies.
Regarding the role of coffee in bladder cancer, our result
suggest a positive correlation between them. Many
constituents in coffee could potentially affect the risk of
bladder cancer through several biological mechanisms.
The main mechanisms, including caffeine, can inhibit the
radiation-damaged DNA repair, modify the apoptotic re-
sponse, and reverse cell-cycle checkpoint function [43,44].
On the other hand, the positive findings could be the
result of residual confounding by smoking [36].
Table 3 Stratified pooled OR and 95% CIs for the highest vesus lowest level of total fluid intake and bladder cancer
risk
Subgroup Number of studies Pooled OR (95% CI) P values for interaction or moderation effect between
the stratified factor and fluid consumption
All studies 21 1.06 (0.88-1.27) <0.001
Study design
Cohort studies 4 0.98 (0.85-1.13) 0.480
Case-control studies 17 1.07 (0.86-1.33) <0.001
Gender
Female 11 1.00 (0.74-1.35) 0.012
Male 10 1.22 (0.95-1.57) <0.001
Geographical Region
Europe and America 17 1.20 (1.02-1.42) <0.001
Asia 4 0.27 (0.10-0.72) <0.001
Asia* 2 0.78 (0.58-1.06) 0.234
Publication time
After 2000 14 0.92 (0.77-1.10) <0.001
Before 2000 7 1.51 (0.93-2.47) <0.001
Type of control
Hospital 8 0.71 (0.44-1.15) <0.001
Population 13 1.21 (1.01-1.45) <0.001
Smoking status
Never 6 0.93 (0.73-1.19) 0.471
Ever 6 0.80 (0.62-1.02) 0.032
Adjustments #
≥ 3 factors 14 1.12 (0.94-1.33) <0.001
< 3 factors 7 0.88 (0.45-1.70) <0.001
Type of beverage
Water 11 1.05 (0.88-1.25) <0.001
Coffee 14 1.17 (1.03-1.33) 0.005
Tea 7 0.96 (0.77-1.21) 0.044
Green tea 5 0.76 (0.66-0.95) 0.317
Black tea 4 0.80 (0.65-0.97) 0.291
Alcoholic beverage
Wine 5 0.90 (0.61, 1.32) <0.001
Beer 6 1.09 (0.79-1.49) 0.001
Liquor 5 0.98 (0.77-1.24) 0.094
Number of beverages
≥ 5 16 1.19 (0.97-1.46) <0.001
< 5 4 0.60 (0.34-1.06) <0.001
*except papers that did not adjust for smoking habits and that calculated total fluid intake based on 3 beverages only.
#adjusted for at least three of the following factors: age, gender, smoking, BMI, education,energy intake and place of residence.
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have different drinking habits, for example, coffee is one
of the major beverages consumed in Europe, while tea is
one of the most popular beverages in Asia. Our study
suggested that high total tea intake decreased the risk ofbladder cancer. Previous research found that polyphe-
nols, which are the active ingredient of tea, provided
protection against bladder cancer by antioxidant activity
[45]. Catechins are the most prevalent polyphenols in
green tea. For black tea, the amount of catechin is about
Figure 3 Funnel plot of studies included evaluating the association between total fluid intake and bladder cancer risk.
(S.E: Standard Error).
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process of fermentation. Therefore, we conducted the
stratified analysis by type of tea to assess the effect of
them, and our results are consistent with previous stud-
ies that suggest a significantly inversed correlation
between green tea consumption and risk of bladder
cancer [46]. Such association was also found in black tea.
Nevertheless, the former is more obvious than the latter.
In addition, findings from the study suggested that wine
consumption was inversely related to bladder cancer risk
because wine contains antioxidant phenolic substances,
which provide protective effects against cancer by blocking
cell-cycle progression in the G0/G1 phase and inducing
apoptosis [47]. However, some authors argued against the
association and advocated that wine consumption could
be harmful because the primary metabolite of ethanol
(acetaldehyde) has been shown to cause damage to the
DNA, which makes alcohol a plausible bladder carcinogen
[48]. Therefore, further high-quality studies are needed
to obtain a better understanding of the effect of wine
consumption on bladder cancer.
When researching the effects of fluid intake on the risk
of bladder cancer, we should consider the multi-factor
interactions. Cigarette smoking is the best established risk
factor for bladder cancer. Current smoking increases the
risk of developing bladder cancer and quitting smoking
markedly decreases the risk. Prevention of cigarette smok-
ing would result in a decrease of 50% of male bladder
cancer cases and 23% of female bladder cancer cases [49].
A recent study found that increased time between
smoking cessation and diagnosis was related to improved
prognosis [50]. Moreover, high fluid intake may be mostbeneficial to the smokers who had been exposed to a high
load of bladder carcinogens, such as urinary caffeine, was
inversely related to urinary cotinine [51]. The Nurses’
Health Study found that a 38% reduction in bladder
cancer risk was associated with increased total fluid intake
among heavy smokers [34]. In our results, we also found
greater consumption of fluid reduced the bladder cancer
incidence among smokers. Furthermore, we also noted
that the associations of fluid intake with bladder cancer
risk were negative in all studies published after 2000,
whereas this was not true in studies published before
2000. This phenomenon may be related to the improve-
ment of the adjustment for smoking in the past decades.
Interestingly, some research found that smoking status
may influence the fluid choice [19]. Specifically, smokers
tended to have high ingest of total fluid, coffee, and
alcoholic beverages. In contrast, smokers were less likely
to have a high consumption of tea.
Although there is a causal relationship between cigarette
smoking and bladder cancer, the influence of smoking on
the risk for superficial or invasive cancer remains unclear.
The Nurses’ Health Study found an approximately 53%
reduction in invasive bladder cancer risk for the highest
total daily fluid intake [34], however, it was not observed
to be significantly associated with non-invasive bladder
cancer risk. They hold that invasive bladder cancer and
non-invasive bladder cancer have distinct molecular
profiles, such that fluid intake may only be associated with
the more aggressive molecular changes. Nevertheless,
results from the EPIC’s (European Prospective Investigation
into Cancer and Nutrition) study do not support that total
fluid intake is associated with low- and high-risk bladder
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the impact of total fluid intake on the risk for the different
pathological types of bladder cancer is needed.
Several limitations of this meta-analysis should be
acknowledged. First, we did not search for unpublished
studies or original data, so publication bias maybe inevit-
able, even though no significant evidence of publication
bias was observed. Second, we extracted the risk estimates
that reflected the greatest degree of control for potential
confounders, but confounding by differences in exposures
to disinfection byproducts or other fluid contaminants
may introduce an unpredictable bias. Third, the differ-
ences in the consumption levels in the lowest and highest
categories and the range of consumption, which varied
across studies, may be responsible for the heterogeneity
among studies in this analysis, and the heterogeneity is
inevitable. Meanwhile, our meta-analysis did not consider
level of consumption in different countries. Future studies
should investigative the different types of fluids and level
of consumption in different countries associated with
bladder cancer risk.
Conclusions
In summary, our meta-analysis of 4 cohort and 17
case-control studies suggested that greater consumption
of fluid may reduce the bladder cancer incidence in
smokers, and may also have a protective effect on bladder
cancer in Asian people. However, there was no conclusive
evidence on this association because of heterogeneity.
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